Key stakeholders in cell and gene therapies meet in Singapore

Our Quality Manager, Richard Makin, attended the Phacilitate Cell and Gene Therapy Forum in Singapore on 19-21 September 2011. The forum focused on the commercial opportunities and challenges (regulatory and political) in the emerging Asian and Australia markets.   A number of novel research and commercial products were showcased including preventive and regenerative therapies. Key stakeholders also discussed partnering opportunities with commercial and academic, hospital-based projects and strategic measures in capitalising on this evolving industry.

Leave a Reply